GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [PSA] shortage is not what most of this community thinks it is — 48 comments in the full submission. View in context.
707
c/glp1aus·submitted 7 months ago by u/arne_ndiaye

[PSA] shortage is not what most of this community thinks it is

PBSbranch of 8 comments

Right, the TGA question again, but with numbers this time. I have 9 data points over 38 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 48 comments →

This branch

8 comments, started 7 months ago
u/zeynep_ndiaye53 points·7 months ago

Yeah, the 2024 rule change was sudden.

replysharereportpermalink
[removed]39 points·7 months ago

[removed by moderator]

replysharereportpermalink
u/cormac_pereira56 points·7 months ago

Small correction: the trial was 12 weeks, not 10. Does not change your point but people will quote it.

replysharereportpermalink
u/kian_solberg26 points·7 months ago·edited

the regulatory shortage is the blocker

replysharereportpermalink
u/emeka_delgado36 points·7 months ago

Small correction: the trial was 12 weeks, not 10.

Disagree on that part. 98.1% and 97.6% on the same vial is normal.

replysharereportpermalink
u/karim_ilunga12 points·7 months ago

Small correction: the trial was 15 weeks, not 34. Does not change your point but people will quote it.

replysharereportpermalink
u/honest_syringe3318 points·7 months ago

unfunded-means-full-price is the NZ reality

replysharereportpermalink
u/arne_ndiayeOP20 points·7 months ago

compounding status changed mid-2024

replysharereportpermalink

← back to the whole thread

About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.